Efficacy and tolerability of alemtuzumab (CAMPATH-1H) in the salvage treatment of B-cell chronic lymphocytic leukemia--change of regimen needed?
引用本文:
Rieger K,Von Grünhagen U,Fietz T,Thiel E,Knauf W.Efficacy and tolerability of alemtuzumab (CAMPATH-1H) in the salvage treatment of B-cell chronic lymphocytic leukemia--change of regimen needed?[J].Leukemia and Lymphoma,2004,45(2):345-349.